Spots Global Cancer Trial Database for recurrent malignant neoplasm

Every month we try and update this database with for recurrent malignant neoplasm cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced Cancers	NCT01624766	Advanced Malign... Metastatic Mali... Recurrent Malig... Refractory Mali...	Anakinra Denosumab Everolimus	18 Years -	M.D. Anderson Cancer Center
Incidence and Prevalence of Cancer in People Living With HIV/AIDS at Cancer Centers in Latin America	NCT04089488	HIV Infection Human Immunodef... Malignant Neopl... Recurrent Malig...	Medical Chart R... Survey Administ...	18 Years -	AIDS Malignancy Consortium
Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic Cancer	NCT01582191	Advanced Malign... Metastatic Mali... Recurrent Malig... Refractory Mali...	Everolimus Laboratory Biom... Pharmacological... Vandetanib	-	M.D. Anderson Cancer Center
Vemurafenib With Sorafenib Tosylate or Crizotinib in Treating Patients With Advanced Malignancies With BRAF Mutations	NCT01531361	Advanced Malign... BRAF Gene Mutat... Metastatic Mali... Recurrent Malig... Refractory Mali...	Crizotinib Laboratory Biom... Pharmacological... Sorafenib Tosyl... Vemurafenib	18 Years -	M.D. Anderson Cancer Center
Financial Distress in Advanced Cancer Patients	NCT04053517	Advanced Malign... Locally Advance... Metastatic Mali... Recurrent Malig... Refractory Mali...	Medical Chart R... Quality-of-Life... Questionnaire A...	18 Years -	M.D. Anderson Cancer Center
Talazoparib in Treating Patients With Recurrent, Refractory, Advanced, or Metastatic Cancers and Alterations in the BRCA Genes	NCT02286687	Advanced Malign... ATM Gene Mutati... BRCA1 Gene Muta... BRCA2 Gene Muta... Metastatic Mali... PALB2 Gene Muta... Recurrent Malig... Refractory Mali...	Laboratory Biom... Pharmacological... Talazoparib	18 Years -	M.D. Anderson Cancer Center
Videos and Questionnaires in Assessing Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic Visits	NCT03856060	Advanced Malign... Locally Advance... Malignant Neopl... Metastatic Mali... Recurrent Malig...	Questionnaire A... Video	18 Years -	M.D. Anderson Cancer Center
Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care	NCT03743649	Delirium Locally Advance... Metastatic Mali... Recurrent Malig...	Haloperidol Lorazepam Placebo Quality-of-Life... Questionnaire A...	18 Years -	M.D. Anderson Cancer Center
Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT II)	NCT02152254	Metastatic Mali... Recurrent Malig...	Targeted Therap... Standard-of-Car...	18 Years -	M.D. Anderson Cancer Center
Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer	NCT02595866	AIDS-Related No... Clinical Stage ... Clinical Stage ... Hepatocellular ... HIV Infection Kaposi Sarcoma Locally Advance... Locally Advance... Metastatic Lung... Metastatic Mali... Metastatic Mela... Non-Hodgkin Lym... Recurrent Class... Recurrent Malig... Refractory Clas... Refractory Mali... Stage III Lung ... Stage IV Lung C... Unresectable Me...	Antiretroviral ... Biopsy Biospecimen Col... Computed Tomogr... Pembrolizumab Positron Emissi...	18 Years -	National Cancer Institute (NCI)
Methylphenidate and Physical Activity to Reduce Cancer Related Fatigue Due to Anti PD1 Immunotherapy	NCT03525873	Advanced Malign... Metastatic Mali... Recurrent Malig...	Laboratory Biom... Methylphenidate Physical Activi... Placebo Quality-of-Life... Questionnaire A...	18 Years -	M.D. Anderson Cancer Center
Talazoparib in Treating Patients With Recurrent, Refractory, Advanced, or Metastatic Cancers and Alterations in the BRCA Genes	NCT02286687	Advanced Malign... ATM Gene Mutati... BRCA1 Gene Muta... BRCA2 Gene Muta... Metastatic Mali... PALB2 Gene Muta... Recurrent Malig... Refractory Mali...	Laboratory Biom... Pharmacological... Talazoparib	18 Years -	M.D. Anderson Cancer Center
Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic Cancer	NCT01582191	Advanced Malign... Metastatic Mali... Recurrent Malig... Refractory Mali...	Everolimus Laboratory Biom... Pharmacological... Vandetanib	-	M.D. Anderson Cancer Center
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment	NCT01790152	Hodgkin Lymphom... Leukemia in Rem... Lymphoblastic L... Osteosarcoma Recurrent Leuke... Recurrent Lymph... Recurrent Malig...	Assessment of T... Laboratory Biom... Quality-of-Life... Questionnaire A...	-	Children's Oncology Group
Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer	NCT02491632	Advanced Malign... Fatigue Metastatic Mali... Recurrent Malig... Refractory Mali...	Dexamethasone Exercise Interv... Laboratory Biom... Quality-of-Life... Questionnaire A...	18 Years -	M.D. Anderson Cancer Center
PCRC-Supported Legacy Intervention in Pediatric Palliative Care	NCT04059393	Care Giver Recurrent Malig... Refractory Mali...	Internet-Based ... Best Practice Quality-of-Life... Questionnaire A...	7 Years - 17 Years	Vanderbilt-Ingram Cancer Center
Caregiver Burden, Quality of Life, and Symptom Distress at Different Palliative Cancer Care Settings	NCT04186884	Advanced Malign... Locally Advance... Metastatic Mali... Recurrent Malig...	Quality-of-Life... Questionnaire A...	18 Years -	M.D. Anderson Cancer Center
Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations	NCT02646319	Advanced Malign... Cervical Squamo... Endometrial Car... Malignant Uteri... Recurrent Bladd... Recurrent Breas... Recurrent Cervi... Recurrent Head ... Recurrent Malig... Recurrent Ovari... Recurrent Prost... Recurrent Renal... Solid Neoplasm Stage III Bladd... Stage III Prost... Stage III Renal... Stage IIIA Brea... Stage IIIA Cerv... Stage IIIA Ovar... Stage IIIB Brea... Stage IIIB Cerv... Stage IIIB Ovar... Stage IIIC Brea... Stage IIIC Ovar... Stage IV Breast... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IVA Bladd... Stage IVA Cervi... Stage IVB Bladd... Stage IVB Cervi...	Laboratory Biom... Nanoparticle Al... Quality-of-Life...	18 Years -	Mayo Clinic
Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT II)	NCT02152254	Metastatic Mali... Recurrent Malig...	Targeted Therap... Standard-of-Car...	18 Years -	M.D. Anderson Cancer Center
Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care	NCT03743649	Delirium Locally Advance... Metastatic Mali... Recurrent Malig...	Haloperidol Lorazepam Placebo Quality-of-Life... Questionnaire A...	18 Years -	M.D. Anderson Cancer Center

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: